Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 24, 2023

SELL
$36.12 - $47.5 $939 - $1,235
-26 Reduced 0.48%
5,424 $217,000
Q1 2023

May 12, 2023

BUY
$35.53 - $43.38 $4,512 - $5,509
127 Added 2.39%
5,450 $222,000
Q4 2022

Feb 10, 2023

SELL
$38.19 - $57.45 $190 - $287
-5 Reduced 0.09%
5,323 $205,000
Q3 2022

Nov 09, 2022

BUY
$51.24 - $58.89 $16,601 - $19,080
324 Added 6.47%
5,328 $283,000
Q2 2022

Aug 16, 2022

BUY
$51.49 - $81.64 $205 - $326
4 Added 0.08%
5,004 $292,000
Q2 2020

Aug 05, 2020

BUY
$30.8 - $52.47 $154,000 - $262,350
5,000 New
5,000 $262,000
Q1 2020

May 11, 2020

SELL
$28.4 - $50.7 $142,000 - $253,500
-5,000 Closed
0 $0
Q4 2019

Feb 13, 2020

BUY
$36.31 - $46.83 $181,550 - $234,150
5,000 New
5,000 $227,000
Q3 2019

Nov 01, 2019

SELL
$35.66 - $44.99 $178,299 - $224,950
-5,000 Closed
0 $0
Q2 2019

Jul 10, 2019

BUY
$36.57 - $47.97 $182,850 - $239,850
5,000 New
5,000 $217,000
Q1 2019

May 14, 2019

SELL
$36.47 - $42.17 $182,350 - $210,850
-5,000 Closed
0 $0
Q3 2018

Nov 13, 2018

BUY
$32.85 - $52.0 $164,250 - $260,000
5,000 New
5,000 $246,000
Q2 2018

Aug 14, 2018

SELL
$27.5 - $39.8 $194,562 - $281,585
-7,075 Closed
0 $0
Q1 2018

May 11, 2018

BUY
$29.98 - $46.35 $10,493 - $16,222
350 Added 5.2%
7,075 $220,000
Q4 2017

Feb 13, 2018

BUY
$31.85 - $46.95 $2,388 - $3,521
75 Added 1.13%
6,725 $307,000
Q3 2017

Nov 13, 2017

BUY
$35.7 - $39.5 $237,405 - $262,675
6,650
6,650 $250,000

Others Institutions Holding PCRX

About Pacira BioSciences, Inc.


  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $892M
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track Svb Wealth LLC Portfolio

Follow Svb Wealth LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Svb Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Svb Wealth LLC with notifications on news.